ATLAS CROSSING LLC

Lobbying for NOVOZYMES NORTH AMERICA INC. · Biosolutions company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · North Carolina · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Issues related to the expansion of HSA for dietary supplements. Issues related to the benefits of dietary supplements. Issues related to the Generally Recognized as Safe designation. Issues related to dietary supplements and the WIC program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.